Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas

American Journal of Clinical Pathology

Volumn 124, Issue 2, 2005, Pages 182-190

  Manazza, Andrea D ^a   Bonello, Lisa ^a   Pagano, Marco ^b   Chiusa, Luigi ^b   Novero, Damenico ^b   Stacchini, Alessandra ^b   Martini, Giuseppe ^b   Vitolo, Umberto ^a   Tarella, Corrado ^a   Inghirami, Giorgio ^a   Palestro, Giorgio ^a   Chiarle, Roberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

CD5; Diffuse large B cell lymphoma; Follicular lymphoma; Histogenesis

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IFOSFAMIDE; IMMUNOGLOBULIN HEAVY CHAIN; METHOTREXATE; MITOXANTRONE; PREDNISONE; PROTEIN BCL 2; PROTEIN BCL 6; VINCRISTINE;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; DENDRITIC CELL; FEMALE; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; GERMINAL CENTER; HUMAN; LARGE CELL LYMPHOMA; MALE; MOLECULAR DYNAMICS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 23044468586     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/8EX5B9JFHPEK82BU     Document Type: Article

References (28)

1. Lankester AC, van Schijndel GM, Cordell JL, et al. CD5 is associated with the human B cell antigen receptor complex. Eur J Immunol. 1994;24:812-816.
2. McHeyzer-Williams MG. B cells as effectors. Curt Opin Immunol. 2003;15:354-361.
3. Baumgarth N. A two-phase model of B-cell activation. Immunol Rev. 2000;176:171-180.
4. Youinou P, Jamin C, Lydyard PM. CD5 expression in human B-cell populations. Immunol Today. 1999;20:312-316.
5. Berland R, Wortis HH. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol. 2002;20:253-300.
6. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol. 2000;13:193-207.
7. Watson P, Wood KM, Lodge A, et al. Monoclonal antibodies recognizing CD5, CD10 and CD23 in formalin-fixed, paraffin-embedded tissue: production and assessment of their value in the diagnosis of small B-cell lymphoma. Histopathology. 2000;36:145-150.
8. Ferry JA, Yang WI, Zukerberg LR, et al. CD5+ extranodal marginal zone B-cell (MALT) lymphoma: a low grade neoplasm with a propensity for bone marrow involvement and relapse. Am J Clin Pathol. 1996;105:31-37.
9. Ballesteros E, Osborne BM, Matsushima AY. CD5+ low-grade marginal zone B-cell lymphomas with localized presentation. Am J Surg Pathol. 1998;22:201-207.
10. Lin CW, O'Brien S, Faber J, et al. De novo CD5+ Burkitt lymphoma/leukemia. Am J Clin Pathol. 1999;112:828-835.
11. Tiesinga JJ, Wu CD, Inghirami G. CD5+ follicle center lymphoma: immunophenotyping detects a unique subset of "floral" follicular lymphoma. Am J Clin Pathol. 2000;114:912-921.
12. Barry TS, Jaffe ES, Kingma DW, et al. CD5+ follicular lymphoma: a clinicopathologic study of three cases. Am J Clin Pathol. 2002;118:589-598.
13. Dong HY, Gorczyca W, Liu Z, et al. B-cell lymphomas with coexpression of CD5 and CD10. Am J Clin Pathol. 2003;119:218-230.
14. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937-1947.
15. Yamaguchi M, Ohno T, Oka K, et al. De novo CD5-positive diffuse large B-cell lymphoma: clinical characteristics and therapeutic outcome. Br J Haematol. 1999;105:1133-1139.
16. Yamaguchi M, Seto M, Okamoto M, et al. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood. 2002;99:815-821.
17. Matolcsy A, Chadbum A, Knowles DM. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Am J Pathol. 1995;147:207-216.
18. Pittaluga S, Wlodarska I, Stul MS, et al. Mantle cell lymphoma: a clinicopathological study of 55 cases. Histopathology. 1995;26:17-24.
19. Nakamura N, Abe M. Histogenesis of CD5-positive and CD5-negative B-cell neoplasms on the aspect of somatic mutation of immunoglobulin heavy chain gene variable region. Fukushima J Med Sci. 2003;49:55-67.
20. Harada S, Suzuki R, Uehira K, et al. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes. Leukemia. 1999;13:1441-1447.
21. H genes in CD10-positive diffuse large B-cell lymphoma. Pathol Int. 2002;52:586-594.
22. Diss TC, Peng H, Wotherspoon AC, et al. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J Pathol. 1993;169:291-295.
23. Molot RJ, Meeker TC, Wittwer CT, et al. Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas. Blood. 1994;83:1626-1631.
24. Luthra R, McBride JA, Hai S, et al. The application of fluorescence-based PCR and PCR-SSCP to monitor the clonal relationship of cells bearing the t(14;18)(q32;q21) in sequential biopsy specimens from patients with follicle center cell lymphoma. Diagn Mol Pathol. 1997;6:71-77.
25. Horsman DE, Gascoyne RD, Coupland RW, et al. Comparison of cytogenetic analysis, Southern analysis, and polymerase chain reaction for the detection of t(14;18) in follicular lymphoma. Am J Clin Pathol. 1995;103:472-478.
26. Kuppers R. Somatic hypermutation and B cell receptor selection in normal and transformed human B cells. Ann N Y Acad Sci. 2003;987:173-179.
27. Pers JO, Jamin C, LeCorre R, et al. Ligation of CD5 on resting B cells, but not on resting T cells, results in apoptosis. Eur J Immunol. 1998;28:4170-4176.
28. Pers JO, Berthou C, Porakishvili N, et al. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia. Leukemia. 2002;16:44-52.